• https://www.facebook.com/fcadgroup
  • http://www.twitter.com/fcadgroup
  • http://www.linkedin.com/company/fcad
  • https://vk.com/fcadgroup
  • https://www.youtube.com/fcadgroup
Please change screen to horizontal for better experience if you are checking Caming on your mobile phone. Email us by [email protected] or visit our sales website www.watson-Int.com
Caming Pharmaceutical Ltd - Focusing on development of pharmaceutical-related chemicals
  • About Caming
  • Key Products
    • Polyethylene Glycol
    • COVID-19 Related
    • Impurities
  • Pharmaceutical Chemicals
    • APIs
    • Intermediates
    • Steroid Hormones
    • Impurities
    • Excipients
    • Others
  • Animal Health
  • Diagnostic Reagents
  • R&D
  • Contact Us
  • Visit FCAD

Tag Archives: «Mubritinib (TAK 165)»

0
Mubritinib (TAK 165) CAS 366017-09-6

Mubritinib (TAK 165) CAS 366017-09-6

In APIs, Pharmaceutical Chemicals, Products

366017-09-6,Mubritinib (TAK 165),TAK 165, TAK165

New Products

  • Zinc oxide CAS 1314-13-2
  • Ipratropium Bromide CAS 66985-17-9
  • 3-(Trifluoromethyl)-1,2-Oxazol-5-Amine CAS 108655-63-6
  • 13-Methyltetradecanoic acid CAS 2485-71-4
  • Barnidipine CAS 104713-75-9
  • Clinafloxacin CAS 105956-97-6
  • Ebselen CAS 60940-34-3
  • Glycofurol CAS 31692-85-0
  • Methylnatrexone bromide CAS 73232-52-7
  • Methyl 3-amino-4-methylthiophene-2-carboxylate CAS 85006-31-1
Copyright © 2026 Caming Pharmaceutical Ltd - Committed to APIs, Intermediates, Impurities, Veterinary Products | A FCAD Company